US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

XILIO THERAPEUTICS, INC.

0.8316

+0.01621.99%

Volume:1.54M

Turnover:1.26M

Market Cap:43.10M

PE:-0.77

High:0.8480

Open:0.8022

Low:0.7842

Close:0.8154

52wk High:1.70

52wk Low:0.6150

Shares:51.83M

Float Shares:23.43M

Volume Ratio:1.05

T/O Rate:6.56%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0848

EPS(LYR):-1.0884

ROE:-277.74%

ROA:-31.66%

PB:6.10

PE(LYR):-0.76

Loading ...

Overview Company News Filings

Xilio Therapeutics Grants Stock Options to New Employee Under Inducement Plan

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Xilio Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview

Xilio Therapeutics Announces Phase 2 Data for Vilastobart in MSS mCRC at SITC 2025

Xilio Therapeutics Inc announces date for special stockholder meeting

Xilio Therapeutics Announces New Clinical Data for Tumor-Activated Immunotherapies at SITC 2025 Annual Meeting

Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer (SITC) 40TH Annual Meeting

THOMSON REUTERS

BRIEF-Xilio Therapeutics Transfers Listing Of Co's Common Stock To Nasdaq Capital Market

Xilio Therapeutics - Transfers Listing of Co's Common Stock to Nasdaq Capital Market,Effective October 6 - SEC Filing

THOMSON REUTERS

Xilio Therapeutics Transfers to Nasdaq Capital Market After Failing to Meet Minimum Bid Price Requirement; Granted Additional 180 Days to Regain Compliance

BRIEF-Xilio Starts Phase 2 Trial for XTX301, Hits $17.5M Milestone in Gilead License Deal

Xilio Therapeutics Extends Cash Runway into Q1 2027 Following $17.5 Million Milestone Achievement

Xilio Therapeutics Inc. Faces Nasdaq Delisting Risk Due to Stockholders' Equity and Minimum Bid Price Non-Compliance

Xilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

BRIEF-Xilio Therapeutics Q2 Net Income USD -15.844 Million

Xilio Therapeutics Reports Q2 2025 Results: Collaboration and License Revenue Surges to $8.1M; Net Loss Widens to $15.8M

Xilio Therapeutics Inc: on Track to Nominate First Development Candidates for Wholly Owned Masked T Cell Engager Programs in H2 2025

THOMSON REUTERS

Xilio Therapeutics Initiated at Outperform by Leerink Partners

Leerink Partners Initiates Xilio Therapeutics at Outperform With $2 Price Target

MT Newswires Live

Catalyst Pharmaceuticals Appoints Daniel Curran, Md, to Its Board of Directors

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/XLO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XLO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLO\",,,,,undefined,":{"symbol":"XLO","market":"US","secType":"STK","nameCN":"XILIO THERAPEUTICS, INC.","latestPrice":0.8316,"timestamp":1762462800000,"preClose":0.8154,"halted":0,"volume":1536639,"delay":0,"floatShares":23433834,"shares":51830450,"eps":-1.084782,"marketStatus":"Pre-Mkt","change":0.0162,"latestTime":"11-07 05:23:36 EST","open":0.8022,"high":0.848,"low":0.7842,"amount":1258633.74492414,"amplitude":0.078244,"askPrice":0.89,"askSize":75,"bidPrice":0.84,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-1.084782,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1762525800000},"marketStatusCode":1,"adr":0,"listingDate":1634875200000,"exchange":"NASDAQ","adjPreClose":0.8316,"postHourTrading":{"tag":"盘后","latestPrice":0.92,"preClose":0.8316,"latestTime":"19:59 EST","volume":349697,"amount":309410.389682,"timestamp":1762477193346},"volumeRatio":1.0530769955784678},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLO\",,,,,undefined,":{"symbol":"XLO","floatShares":23433834,"roa":"-31.66%","roe":"-277.74%","lyrEps":-1.088384,"volumeRatio":1.0530769955784678,"shares":51830450,"dividePrice":0,"high":0.848,"amplitude":0.078244,"preClose":0.8154,"low":0.7842,"week52Low":0.615,"pbRate":"6.10","psRate":"2.87","week52High":1.7,"institutionHeld":0,"latestPrice":0.8316,"committee":0.860465,"eps":-1.084782,"divideRate":0,"volume":1536639,"delay":0,"ttmEps":-1.084782,"open":0.8022,"prevYearClose":0.955,"prevWeekClose":0.7967,"prevMonthClose":0.7967,"prevQuarterClose":0.8427,"fiveDayClose":0.8036,"twentyDayClose":0.8383,"sixtyDayClose":0.7147},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-14","symbol":"XLO","fiscalQuarterEnding":"2025/06","expectedEps":-0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.16},{"market":"US","date":"2025-05-08","symbol":"XLO","fiscalQuarterEnding":"2025/03","expectedEps":0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2025-03-11","symbol":"XLO","fiscalQuarterEnding":"2024/12","expectedEps":-0.22,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2024-11-07","symbol":"XLO","fiscalQuarterEnding":"2024/09","expectedEps":-0.25,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.22},{"market":"US","date":"2024-08-08","symbol":"XLO","fiscalQuarterEnding":"2024/06","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1754456400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/XLO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"XLO","date":"2025-11-05","current":-0.766606,"percent":0.532323,"low":-8.819798,"twenty":-1.019867,"median":-0.758032,"eighty":-0.56178,"high":-0.169617,"avg":-1.219657,"sd":1.471557,"marketCap":41557654},"quantilePoints":[{"date":"2021-10-22","current":-5.619943,"twenty":-5.655644,"median":-5.655644,"eighty":-5.634223,"marketCap":423962880},{"date":"2021-10-29","current":-5.897428,"twenty":-5.742879,"median":-5.655644,"eighty":-5.632588,"marketCap":444896047},{"date":"2021-11-05","current":-7.534236,"twenty":-7.275719,"median":-5.778004,"eighty":-5.653191,"marketCap":568375236},{"date":"2021-11-12","current":-7.783621,"twenty":-8.139785,"median":-6.784325,"eighty":-5.655644,"marketCap":587188588},{"date":"2021-11-19","current":-7.994369,"twenty":-8.332268,"median":-7.783621,"eighty":-5.669463,"marketCap":603087196},{"date":"2021-11-26","current":-6.993317,"twenty":-8.285904,"median":-7.699322,"eighty":-5.707754,"marketCap":527568808},{"date":"2021-12-03","current":-4.59754,"twenty":-8.14962,"median":-7.070591,"eighty":-5.652373,"marketCap":353417461},{"date":"2021-12-10","current":-3.644608,"twenty":-8.092015,"median":-6.680707,"eighty":-5.383906,"marketCap":280164654},{"date":"2021-12-17","current":-3.769058,"twenty":-8.017551,"median":-5.735855,"eighty":-4.164453,"marketCap":289731252},{"date":"2021-12-23","current":-5.689144,"twenty":-8.011931,"median":-5.689668,"eighty":-4.138852,"marketCap":437330192},{"date":"2021-12-31","current":-5.689144,"twenty":-7.994369,"median":-5.689144,"eighty":-4.156631,"marketCap":437330192},{"date":"2022-01-07","current":-5.091784,"twenty":-7.797671,"median":-5.658171,"eighty":-4.266858,"marketCap":391410521},{"date":"2022-01-14","current":-5.162898,"twenty":-7.783621,"median":-5.653587,"eighty":-4.59754,"marketCap":396877149},{"date":"2022-01-21","current":-4.842884,"twenty":-7.716182,"median":-5.64292,"eighty":-4.788126,"marketCap":372277325},{"date":"2022-01-28","current":-4.77177,"twenty":-7.567253,"median":-5.591843,"eighty":-4.822972,"marketCap":366810698},{"date":"2022-02-04","current":-3.598384,"twenty":-7.225139,"median":-5.49358,"eighty":-4.4546,"marketCap":276611346},{"date":"2022-02-11","current":-4.739768,"twenty":-7.024227,"median":-5.32737,"eighty":-4.153075,"marketCap":364350716},{"date":"2022-02-18","current":-4.82155,"twenty":-6.909018,"median":-5.17001,"eighty":-4.244813,"marketCap":370637337},{"date":"2022-02-25","current":-4.675765,"twenty":-6.763601,"median":-5.152231,"eighty":-4.222767,"marketCap":359430751},{"date":"2022-03-04","current":-3.096766,"twenty":-6.21074,"median":-5.107785,"eighty":-4.106851,"marketCap":234734857},{"date":"2022-03-11","current":-2.663652,"twenty":-5.825774,"median":-5.088228,"eighty":-3.781858,"marketCap":201904807},{"date":"2022-03-18","current":-2.77554,"twenty":-5.735355,"median":-5.013559,"eighty":-3.685854,"marketCap":210385903},{"date":"2022-03-25","current":-2.526499,"twenty":-5.698992,"median":-4.963778,"eighty":-3.539359,"marketCap":191508625},{"date":"2022-04-01","current":-2.475969,"twenty":-5.691597,"median":-4.880219,"eighty":-3.443152,"marketCap":187678452},{"date":"2022-04-08","current":-2.537327,"twenty":-5.689563,"median":-4.835772,"eighty":-3.159567,"marketCap":192329376},{"date":"2022-04-14","current":-2.180008,"twenty":-5.689144,"median":-4.77177,"eighty":-2.747387,"marketCap":165244585},{"date":"2022-04-22","current":-1.454542,"twenty":-5.689144,"median":-4.707766,"eighty":-2.648493,"marketCap":110254251},{"date":"2022-04-29","current":-1.27492,"twenty":-5.677766,"median":-4.57265,"eighty":-2.569089,"marketCap":96638949},{"date":"2022-05-06","current":-1.311037,"twenty":-5.658676,"median":-4.385974,"eighty":-2.547433,"marketCap":99376596},{"date":"2022-05-13","current":-1.14627,"twenty":-5.655644,"median":-4.188632,"eighty":-2.530108,"marketCap":92258714},{"date":"2022-05-20","current":-0.816335,"twenty":-5.654821,"median":-4.133519,"eighty":-2.502678,"marketCap":65703535},{"date":"2022-05-27","current":-1.102052,"twenty":-5.652774,"median":-3.930511,"eighty":-2.265187,"marketCap":88699772},{"date":"2022-06-03","current":-0.945588,"twenty":-5.649828,"median":-3.790392,"eighty":-1.806807,"marketCap":76106594},{"date":"2022-06-10","current":-1.017017,"twenty":-5.638325,"median":-3.710388,"eighty":-1.458346,"marketCap":81855654},{"date":"2022-06-17","current":-0.70749,"twenty":-5.619943,"median":-3.662386,"eighty":-1.354377,"marketCap":56943063},{"date":"2022-06-24","current":-0.812934,"twenty":-5.619943,"median":-3.598384,"eighty":-1.267697,"marketCap":65429770},{"date":"2022-07-01","current":-0.979602,"twenty":-5.563744,"median":-3.523713,"eighty":-1.159876,"marketCap":78844242},{"date":"2022-07-08","current":-1.17008,"twenty":-5.533214,"median":-3.456155,"eighty":-1.140148,"marketCap":94175067},{"date":"2022-07-15","current":-1.037426,"twenty":-5.49998,"median":-3.32776,"eighty":-1.085725,"marketCap":83498242},{"date":"2022-07-22","current":-1.057834,"twenty":-5.470823,"median":-3.149101,"eighty":-1.083005,"marketCap":85140831},{"date":"2022-07-29","current":-0.986405,"twenty":-5.364184,"median":-2.77554,"eighty":-1.046269,"marketCap":79391771},{"date":"2022-08-05","current":-1.102052,"twenty":-5.320424,"median":-2.696136,"eighty":-1.036746,"marketCap":88699772},{"date":"2022-08-12","current":-0.822578,"twenty":-5.273125,"median":-2.638387,"eighty":-1.029943,"marketCap":67383911},{"date":"2022-08-19","current":-0.792483,"twenty":-5.1885,"median":-2.582443,"eighty":-1.019739,"marketCap":64918646},{"date":"2022-08-26","current":-0.752358,"twenty":-5.16432,"median":-2.558983,"eighty":-0.995929,"marketCap":61631626},{"date":"2022-09-02","current":-0.692169,"twenty":-5.154364,"median":-2.548154,"eighty":-0.989126,"marketCap":56701096},{"date":"2022-09-09","current":-0.919548,"twenty":-5.147964,"median":-2.539131,"eighty":-0.97416,"marketCap":75327543},{"date":"2022-09-16","current":-1.003143,"twenty":-5.130186,"median":-2.530108,"eighty":-0.962595,"marketCap":82175502},{"date":"2022-09-23","current":-1.003143,"twenty":-5.105296,"median":-2.513866,"eighty":-0.964636,"marketCap":82175502},{"date":"2022-09-30","current":-0.973049,"twenty":-5.093206,"median":-2.475969,"eighty":-0.964636,"marketCap":79710236},{"date":"2022-10-07","current":-0.916204,"twenty":-5.08965,"median":-2.286481,"eighty":-0.962595,"marketCap":75053625},{"date":"2022-10-14","current":-0.769077,"twenty":-5.06476,"median":-1.858781,"eighty":-0.94028,"marketCap":63001218},{"date":"2022-10-21","current":-0.728951,"twenty":-5.046982,"median":-1.5525,"eighty":-0.91821,"marketCap":59714198},{"date":"2022-10-28","current":-0.782452,"twenty":-5.007158,"median":-1.454542,"eighty":-0.886404,"marketCap":64096891},{"date":"2022-11-04","current":-0.765733,"twenty":-4.979423,"median":-1.388688,"eighty":-0.850349,"marketCap":62727299},{"date":"2022-11-11","current":-0.800435,"twenty":-4.969467,"median":-1.311037,"eighty":-0.824584,"marketCap":68402762},{"date":"2022-11-18","current":-0.830646,"twenty":-4.957378,"median":-1.265891,"eighty":-0.82124,"marketCap":70984515},{"date":"2022-11-25","current":-0.849568,"twenty":-4.938888,"median":-1.206298,"eighty":-0.820572,"marketCap":72601537},{"date":"2022-12-02","current":-0.779332,"twenty":-4.887686,"median":-1.17008,"eighty":-0.816068,"marketCap":66599372},{"date":"2022-12-09","current":-0.737639,"twenty":-4.841462,"median":-1.144569,"eighty":-0.808598,"marketCap":63036442},{"date":"2022-12-16","current":-0.750468,"twenty":-4.837906,"median":-1.129263,"eighty":-0.802075,"marketCap":64132728},{"date":"2022-12-23","current":-0.753675,"twenty":-4.830083,"median":-1.115833,"eighty":-0.793821,"marketCap":64406800},{"date":"2022-12-30","current":-0.862717,"twenty":-4.811594,"median":-1.102052,"eighty":-0.792483,"marketCap":73725230},{"date":"2023-01-06","current":-0.871537,"twenty":-4.77177,"median":-1.090148,"eighty":-0.792483,"marketCap":74478927},{"date":"2023-01-13","current":-0.853096,"twenty":-4.74688,"median":-1.061235,"eighty":-0.792483,"marketCap":72903016},{"date":"2023-01-20","current":-0.894789,"twenty":-4.74119,"median":-1.053301,"eighty":-0.795158,"marketCap":76465945},{"date":"2023-01-27","current":-1.372651,"twenty":-4.688566,"median":-1.055567,"eighty":-0.795827,"marketCap":117302597},{"date":"2023-02-03","current":-1.16098,"twenty":-4.613185,"median":-1.081644,"eighty":-0.799513,"marketCap":99213879},{"date":"2023-02-10","current":-0.962138,"twenty":-4.577628,"median":-1.082826,"eighty":-0.801513,"marketCap":82221447},{"date":"2023-02-17","current":-1.148152,"twenty":-4.515758,"median":-1.061235,"eighty":-0.802368,"marketCap":98117593},{"date":"2023-02-24","current":-1.122495,"twenty":-4.501535,"median":-1.084009,"eighty":-0.802643,"marketCap":95925021},{"date":"2023-03-03","current":-0.945045,"twenty":-4.362862,"median":-1.082826,"eighty":-0.804607,"marketCap":83373763},{"date":"2023-03-10","current":-0.864219,"twenty":-4.26828,"median":-1.057834,"eighty":-0.807261,"marketCap":76243112},{"date":"2023-03-17","current":-0.913958,"twenty":-4.219922,"median":-1.04933,"eighty":-0.8088,"marketCap":80631205},{"date":"2023-03-24","current":-0.95748,"twenty":-4.169431,"median":-1.040827,"eighty":-0.809202,"marketCap":84470786},{"date":"2023-03-31","current":-0.985458,"twenty":-4.145964,"median":-1.035725,"eighty":-0.811441,"marketCap":86939088},{"date":"2023-04-06","current":-0.935719,"twenty":-4.134585,"median":-1.030623,"eighty":-0.814116,"marketCap":82550995},{"date":"2023-04-14","current":-1.032089,"twenty":-4.106851,"median":-1.030623,"eighty":-0.816068,"marketCap":91052925},{"date":"2023-04-21","current":-0.917067,"twenty":-4.017114,"median":-1.026546,"eighty":-0.816335,"marketCap":80905461},{"date":"2023-04-28","current":-0.948646,"twenty":-3.911443,"median":-1.02382,"eighty":-0.817495,"marketCap":83691451},{"date":"2023-05-05","current":-0.911322,"twenty":-3.845861,"median":-1.021746,"eighty":-0.820572,"marketCap":80398672},{"date":"2023-05-12","current":-0.980924,"twenty":-3.781858,"median":-1.017017,"eighty":-0.823915,"marketCap":87807424},{"date":"2023-05-19","current":-0.962532,"twenty":-3.746301,"median":-1.012271,"eighty":-0.827811,"marketCap":86161034},{"date":"2023-05-26","current":-0.94108,"twenty":-3.710744,"median":-1.010214,"eighty":-0.834494,"marketCap":84240763},{"date":"2023-06-02","current":-0.892033,"twenty":-3.707189,"median":-1.007219,"eighty":-0.840742,"marketCap":79850365},{"date":"2023-06-09","current":-0.921155,"twenty":-3.693676,"median":-1.004815,"eighty":-0.843978,"marketCap":82457163},{"date":"2023-06-16","current":-0.836856,"twenty":-3.65883,"median":-1.003143,"eighty":-0.837538,"marketCap":74911167},{"date":"2023-06-23","current":-0.833791,"twenty":-3.644608,"median":-0.99838,"eighty":-0.836856,"marketCap":74636767},{"date":"2023-06-30","current":-0.82766,"twenty":-3.607629,"median":-0.996609,"eighty":-0.830049,"marketCap":74087967},{"date":"2023-07-07","current":-0.78781,"twenty":-3.566382,"median":-0.993208,"eighty":-0.824593,"marketCap":70520769},{"date":"2023-07-14","current":-0.815398,"twenty":-3.536514,"median":-0.99316,"eighty":-0.822592,"marketCap":72990368},{"date":"2023-07-21","current":-0.842987,"twenty":-3.522291,"median":-0.989806,"eighty":-0.82124,"marketCap":75459967},{"date":"2023-07-28","current":-0.849118,"twenty":-3.486734,"median":-0.985931,"eighty":-0.822592,"marketCap":76008766},{"date":"2023-08-04","current":-0.842987,"twenty":-3.454022,"median":-0.985458,"eighty":-0.822602,"marketCap":75459967},{"date":"2023-08-11","current":-0.873641,"twenty":-3.441984,"median":-0.980924,"eighty":-0.823797,"marketCap":78203965},{"date":"2023-08-18","current":-0.878604,"twenty":-3.372515,"median":-0.979241,"eighty":-0.82539,"marketCap":74028579},{"date":"2023-08-25","current":-0.940627,"twenty":-3.299607,"median":-0.975457,"eighty":-0.826964,"marketCap":79254417},{"date":"2023-09-01","current":-0.937361,"twenty":-3.233197,"median":-0.973023,"eighty":-0.82766,"marketCap":78979228},{"date":"2023-09-08","current":-0.885104,"twenty":-3.159567,"median":-0.971728,"eighty":-0.82766,"marketCap":74576205},{"date":"2023-09-15","current":-0.829581,"twenty":-2.981269,"median":-0.970062,"eighty":-0.826617,"marketCap":69897993},{"date":"2023-09-22","current":-0.76426,"twenty":-2.79503,"median":-0.966806,"eighty":-0.822588,"marketCap":64394214},{"date":"2023-09-29","current":-0.70547,"twenty":-2.766156,"median":-0.965603,"eighty":-0.816906,"marketCap":59440813},{"date":"2023-10-06","current":-0.646681,"twenty":-2.727897,"median":-0.962595,"eighty":-0.815979,"marketCap":54487412},{"date":"2023-10-13","current":-0.604222,"twenty":-2.71346,"median":-0.962532,"eighty":-0.812453,"marketCap":50909955},{"date":"2023-10-20","current":-0.636883,"twenty":-2.666539,"median":-0.960045,"eighty":-0.808397,"marketCap":53661845},{"date":"2023-10-27","current":-0.679342,"twenty":-2.665096,"median":-0.95957,"eighty":-0.806065,"marketCap":57239301},{"date":"2023-11-03","current":-0.816517,"twenty":-2.648493,"median":-0.95748,"eighty":-0.802222,"marketCap":68797237},{"date":"2023-11-10","current":-0.522571,"twenty":-2.614566,"median":-0.947902,"eighty":-0.798373,"marketCap":44030232},{"date":"2023-11-17","current":-0.442347,"twenty":-2.594354,"median":-0.946599,"eighty":-0.792483,"marketCap":35925248},{"date":"2023-11-24","current":-0.401672,"twenty":-2.584248,"median":-0.945588,"eighty":-0.790684,"marketCap":32621777},{"date":"2023-12-01","current":-0.305101,"twenty":-2.570532,"median":-0.942446,"eighty":-0.788267,"marketCap":24778786},{"date":"2023-12-08","current":-0.311846,"twenty":-2.563314,"median":-0.941074,"eighty":-0.783066,"marketCap":25326611},{"date":"2023-12-15","current":-0.247443,"twenty":-2.556095,"median":-0.940627,"eighty":-0.780271,"marketCap":20096115},{"date":"2023-12-22","current":-0.180091,"twenty":-2.551764,"median":-0.938014,"eighty":-0.774301,"marketCap":14626118},{"date":"2023-12-29","current":-0.193209,"twenty":-2.551764,"median":-0.937361,"eighty":-0.770792,"marketCap":15691487},{"date":"2024-01-05","current":-0.245647,"twenty":-2.547433,"median":-0.936267,"eighty":-0.769457,"marketCap":19950212},{"date":"2024-01-12","current":-0.275645,"twenty":-2.54238,"median":-0.935334,"eighty":-0.766195,"marketCap":22386522},{"date":"2024-01-19","current":-0.233071,"twenty":-2.539492,"median":-0.934949,"eighty":-0.764849,"marketCap":18928889},{"date":"2024-01-26","current":-0.216937,"twenty":-2.534439,"median":-0.93261,"eighty":-0.754249,"marketCap":17618512},{"date":"2024-02-02","current":-0.227106,"twenty":-2.530108,"median":-0.92518,"eighty":-0.752358,"marketCap":18444380},{"date":"2024-02-09","current":-0.203378,"twenty":-2.528664,"median":-0.923284,"eighty":-0.751224,"marketCap":16517355},{"date":"2024-02-16","current":-0.199107,"twenty":-2.525055,"median":-0.920389,"eighty":-0.749014,"marketCap":16170491},{"date":"2024-02-23","current":-0.18643,"twenty":-2.519281,"median":-0.919085,"eighty":-0.746197,"marketCap":15140909},{"date":"2024-03-01","current":-0.240325,"twenty":-2.504121,"median":-0.917067,"eighty":-0.739651,"marketCap":19518008},{"date":"2024-03-08","current":-0.270832,"twenty":-2.496181,"median":-0.915351,"eighty":-0.735638,"marketCap":21995611},{"date":"2024-03-15","current":-0.219174,"twenty":-2.466585,"median":-0.913491,"eighty":-0.731225,"marketCap":17800203},{"date":"2024-03-22","current":-0.238122,"twenty":-2.421829,"median":-0.911599,"eighty":-0.715205,"marketCap":19339070},{"date":"2024-03-28","current":-0.216598,"twenty":-2.392955,"median":-0.911029,"eighty":-0.70547,"marketCap":17590983},{"date":"2024-04-05","current":-0.545745,"twenty":-2.180008,"median":-0.910426,"eighty":-0.68914,"marketCap":41697098},{"date":"2024-04-12","current":-0.613532,"twenty":-2.057292,"median":-0.907037,"eighty":-0.679342,"marketCap":46876301},{"date":"2024-04-19","current":-0.577442,"twenty":-1.858781,"median":-0.904632,"eighty":-0.663875,"marketCap":44118872},{"date":"2024-04-26","current":-0.455638,"twenty":-1.793814,"median":-0.901286,"eighty":-0.653213,"marketCap":34812547},{"date":"2024-05-03","current":-0.507198,"twenty":-1.570039,"median":-0.897996,"eighty":-0.636883,"marketCap":38751930},{"date":"2024-05-10","current":-0.608637,"twenty":-1.534961,"median":-0.892115,"eighty":-0.623819,"marketCap":46502316},{"date":"2024-05-17","current":-0.561705,"twenty":-1.473562,"median":-0.887764,"eighty":-0.608637,"marketCap":39859128},{"date":"2024-05-24","current":-0.556504,"twenty":-1.454542,"median":-0.885503,"eighty":-0.604222,"marketCap":39490062},{"date":"2024-05-31","current":-0.483742,"twenty":-1.448767,"median":-0.881558,"eighty":-0.597071,"marketCap":34326828},{"date":"2024-06-07","current":-0.53057,"twenty":-1.404749,"median":-0.876706,"eighty":-0.586439,"marketCap":37649763},{"date":"2024-06-14","current":-0.546175,"twenty":-1.387604,"median":-0.876079,"eighty":-0.580482,"marketCap":38757109},{"date":"2024-06-21","current":-0.496031,"twenty":-1.379022,"median":-0.873673,"eighty":-0.570621,"marketCap":35198837},{"date":"2024-06-28","current":-0.488956,"twenty":-1.374775,"median":-0.873641,"eighty":-0.569679,"marketCap":34696841},{"date":"2024-07-05","current":-0.448904,"twenty":-1.357353,"median":-0.873641,"eighty":-0.561773,"marketCap":31854652},{"date":"2024-07-12","current":-0.520114,"twenty":-1.333588,"median":-0.87282,"eighty":-0.555857,"marketCap":36907841},{"date":"2024-07-15","current":-0.53057,"twenty":-1.329066,"median":-0.872339,"eighty":-0.554184,"marketCap":37649763},{"date":"2024-08-02","current":-0.494158,"twenty":-1.324544,"median":-0.872339,"eighty":-0.551376,"marketCap":35065956},{"date":"2024-08-09","current":-0.483847,"twenty":-1.311037,"median":-0.871537,"eighty":-0.546175,"marketCap":31707006},{"date":"2024-08-16","current":-0.556692,"twenty":-1.27492,"median":-0.868973,"eighty":-0.546175,"marketCap":36480567},{"date":"2024-08-23","current":-0.597874,"twenty":-1.27323,"median":-0.865924,"eighty":-0.546175,"marketCap":39179250},{"date":"2024-08-30","current":-0.538985,"twenty":-1.267697,"median":-0.863468,"eighty":-0.546175,"marketCap":35320221},{"date":"2024-09-06","current":-0.518595,"twenty":-1.264807,"median":-0.862048,"eighty":-0.54616,"marketCap":33984066},{"date":"2024-09-13","current":-0.549985,"twenty":-1.263703,"median":-0.858314,"eighty":-0.545667,"marketCap":36041042},{"date":"2024-09-20","current":-0.524699,"twenty":-1.232207,"median":-0.857152,"eighty":-0.544779,"marketCap":34384033},{"date":"2024-09-27","current":-0.504376,"twenty":-1.201879,"median":-0.854893,"eighty":-0.540606,"marketCap":33052273},{"date":"2024-10-04","current":-0.486602,"twenty":-1.189844,"median":-0.850349,"eighty":-0.531977,"marketCap":31887532},{"date":"2024-10-11","current":-0.528522,"twenty":-1.186983,"median":-0.849328,"eighty":-0.53057,"marketCap":34634562},{"date":"2024-10-18","current":-0.529863,"twenty":-1.186643,"median":-0.84452,"eighty":-0.530429,"marketCap":34722467},{"date":"2024-10-25","current":-0.62108,"twenty":-1.173809,"median":-0.842987,"eighty":-0.530429,"marketCap":40700006},{"date":"2024-10-31","current":-0.918877,"twenty":-1.170289,"median":-0.84264,"eighty":-0.53057,"marketCap":60214912},{"date":"2024-11-08","current":-0.727841,"twenty":-1.17008,"median":-0.842987,"eighty":-0.53057,"marketCap":45710590},{"date":"2024-11-15","current":-0.669964,"twenty":-1.168468,"median":-0.840267,"eighty":-0.53057,"marketCap":42075719},{"date":"2024-11-22","current":-0.643941,"twenty":-1.163546,"median":-0.839921,"eighty":-0.531625,"marketCap":40441428},{"date":"2024-11-29","current":-0.76293,"twenty":-1.160538,"median":-0.835323,"eighty":-0.532657,"marketCap":47914300},{"date":"2024-12-06","current":-0.734933,"twenty":-1.159035,"median":-0.830725,"eighty":-0.534491,"marketCap":46155977},{"date":"2024-12-13","current":-0.720934,"twenty":-1.15649,"median":-0.82862,"eighty":-0.53653,"marketCap":45276816},{"date":"2024-12-20","current":-0.65654,"twenty":-1.152,"median":-0.82766,"eighty":-0.53657,"marketCap":41232673},{"date":"2024-12-27","current":-0.682437,"twenty":-1.147776,"median":-0.825921,"eighty":-0.53657,"marketCap":42859122},{"date":"2025-01-03","current":-0.748931,"twenty":-1.14627,"median":-0.822602,"eighty":-0.53657,"marketCap":47035139},{"date":"2025-01-10","current":-0.783928,"twenty":-1.145209,"median":-0.822578,"eighty":-0.537107,"marketCap":49233042},{"date":"2025-01-17","current":-0.797927,"twenty":-1.143284,"median":-0.817491,"eighty":-0.538636,"marketCap":50112204},{"date":"2025-01-24","current":-0.580737,"twenty":-1.142869,"median":-0.816517,"eighty":-0.540201,"marketCap":36472013},{"date":"2025-01-31","current":-0.486385,"twenty":-1.140266,"median":-0.816335,"eighty":-0.53657,"marketCap":30546465},{"date":"2025-02-07","current":-0.482956,"twenty":-1.13297,"median":-0.815659,"eighty":-0.532822,"marketCap":30331071},{"date":"2025-02-14","current":-0.902917,"twenty":-1.125202,"median":-0.815429,"eighty":-0.53057,"marketCap":56705915},{"date":"2025-02-21","current":-0.771637,"twenty":-1.122495,"median":-0.815398,"eighty":-0.531274,"marketCap":48461135},{"date":"2025-02-28","current":-0.649413,"twenty":-1.121121,"median":-0.810785,"eighty":-0.532657,"marketCap":40785074},{"date":"2025-03-07","current":-0.678968,"twenty":-1.117838,"median":-0.809202,"eighty":-0.534491,"marketCap":42641227},{"date":"2025-03-14","current":-0.710276,"twenty":-1.115867,"median":-0.80603,"eighty":-0.53653,"marketCap":41367199},{"date":"2025-03-21","current":-0.696942,"twenty":-1.110216,"median":-0.804926,"eighty":-0.53657,"marketCap":40590594},{"date":"2025-03-28","current":-0.648849,"twenty":-1.102052,"median":-0.802148,"eighty":-0.53657,"marketCap":37789636},{"date":"2025-04-04","current":-0.622447,"twenty":-1.09797,"median":-0.800186,"eighty":-0.536838,"marketCap":36251956},{"date":"2025-04-11","current":-0.588045,"twenty":-1.090488,"median":-0.797927,"eighty":-0.537939,"marketCap":34248313},{"date":"2025-04-17","current":-0.67374,"twenty":-1.087559,"median":-0.796877,"eighty":-0.53939,"marketCap":39239300},{"date":"2025-04-25","current":-0.744946,"twenty":-1.083536,"median":-0.792483,"eighty":-0.541079,"marketCap":43386374},{"date":"2025-05-02","current":-0.671162,"twenty":-1.080126,"median":-0.792322,"eighty":-0.54163,"marketCap":39089156},{"date":"2025-05-09","current":-0.686464,"twenty":-1.071492,"median":-0.790557,"eighty":-0.542848,"marketCap":37277076},{"date":"2025-05-16","current":-0.762738,"twenty":-1.071492,"median":-0.789848,"eighty":-0.543277,"marketCap":41418973},{"date":"2025-05-23","current":-0.855362,"twenty":-1.060555,"median":-0.79216,"eighty":-0.543653,"marketCap":46448698},{"date":"2025-05-30","current":-0.919156,"twenty":-1.057834,"median":-0.792483,"eighty":-0.545155,"marketCap":49912932},{"date":"2025-06-06","current":-0.646814,"twenty":-1.056958,"median":-0.792322,"eighty":-0.545357,"marketCap":35123915},{"date":"2025-06-13","current":-0.651868,"twenty":-1.053301,"median":-0.790557,"eighty":-0.545745,"marketCap":35398361},{"date":"2025-06-20","current":-0.629935,"twenty":-1.051485,"median":-0.788953,"eighty":-0.546031,"marketCap":34207369},{"date":"2025-06-27","current":-0.647958,"twenty":-1.04831,"median":-0.786803,"eighty":-0.54616,"marketCap":35186054},{"date":"2025-07-03","current":-0.665599,"twenty":-1.044442,"median":-0.783892,"eighty":-0.546175,"marketCap":36144026},{"date":"2025-07-11","current":-0.709368,"twenty":-1.041423,"median":-0.782539,"eighty":-0.546175,"marketCap":38520832},{"date":"2025-07-18","current":-0.691346,"twenty":-1.040286,"median":-0.782066,"eighty":-0.546328,"marketCap":37542147},{"date":"2025-07-25","current":-0.658066,"twenty":-1.038426,"median":-0.77892,"eighty":-0.547154,"marketCap":35734946},{"date":"2025-08-01","current":-0.618683,"twenty":-1.036513,"median":-0.775821,"eighty":-0.549045,"marketCap":33596338},{"date":"2025-08-08","current":-0.624977,"twenty":-1.034776,"median":-0.772918,"eighty":-0.549985,"marketCap":33938101},{"date":"2025-08-15","current":-0.670671,"twenty":-1.032863,"median":-0.770792,"eighty":-0.55082,"marketCap":36419472},{"date":"2025-08-22","current":-0.617635,"twenty":-1.031209,"median":-0.769929,"eighty":-0.551376,"marketCap":34724699},{"date":"2025-08-29","current":-0.636533,"twenty":-1.030623,"median":-0.769394,"eighty":-0.551376,"marketCap":35787171},{"date":"2025-09-05","current":-0.661884,"twenty":-1.029262,"median":-0.768301,"eighty":-0.552107,"marketCap":37212439},{"date":"2025-09-12","current":-0.67267,"twenty":-1.026894,"median":-0.765733,"eighty":-0.553877,"marketCap":37818825},{"date":"2025-09-19","current":-0.703736,"twenty":-1.026191,"median":-0.764997,"eighty":-0.555533,"marketCap":39565426},{"date":"2025-09-26","current":-0.699864,"twenty":-1.025051,"median":-0.763296,"eighty":-0.556579,"marketCap":39347749},{"date":"2025-10-03","current":-0.737475,"twenty":-1.02382,"median":-0.763296,"eighty":-0.557899,"marketCap":41462328},{"date":"2025-10-10","current":-0.772782,"twenty":-1.023522,"median":-0.763296,"eighty":-0.560508,"marketCap":43447336},{"date":"2025-10-17","current":-0.698758,"twenty":-1.022012,"median":-0.76293,"eighty":-0.561705,"marketCap":39285555},{"date":"2025-10-24","current":-0.712693,"twenty":-1.020384,"median":-0.762738,"eighty":-0.561728,"marketCap":40069009},{"date":"2025-10-31","current":-0.74083,"twenty":-1.020145,"median":-0.759092,"eighty":-0.56177,"marketCap":41650949},{"date":"2025-11-05","current":-0.739171,"twenty":-1.019867,"median":-0.758032,"eighty":-0.56178,"marketCap":41557654}],"updateTime":1762502093453},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2580225553","title":"Xilio Therapeutics Grants Stock Options to New Employee Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2580225553","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580225553?lang=en_us&edition=fundamental","pubTime":"2025-11-04 05:30","pubTimestamp":1762205418,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc. has granted a non-qualified stock option to purchase 5,700 shares of its common stock to a new employee. The options have an exercise price of $0.7967 per share, matching the closing price on October 31, 2025. The options vest 25% after one year of employment, with the remaining 75% vesting in 36 equal monthly installments, and carry a ten-year term.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on November 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL2wRy4T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B64PRP62.GBP","NDAQ","IE00BKPKM429.USD","LU0314104364.USD","LU2095319765.USD","BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4139","IE00BGHQF748.EUR","LU2210150020.SGD","BK4588","XLO"],"gpt_icon":0},{"id":"2580225381","title":"Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2580225381","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580225381?lang=en_us&edition=fundamental","pubTime":"2025-11-04 05:30","pubTimestamp":1762205401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUA63WZPX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2580719290","title":"Xilio Therapeutics Inc  expected to post a loss of 3 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580719290","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580719290?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:31","pubTimestamp":1762173115,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc  expected to post a loss of3cents a share - Earnings Preview Xilio Therapeutics Inc XLO.OQ XLO.O is expected to  show a rise in quarterly revenue when it reports  results on Nov","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL8N3WF0Z6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2579142463","title":"Xilio Therapeutics Announces Phase 2 Data for Vilastobart in MSS mCRC at SITC 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2579142463","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579142463?lang=en_us&edition=fundamental","pubTime":"2025-10-30 21:02","pubTimestamp":1761829368,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc. announced that it will present new Phase 2 data for vilastobart, a tumor-activated, Fc-enhanced anti-CTLA-4 therapy, at the Society for Immunotherapy of Cancer  40th Annual Meeting, scheduled for November 5-9, 2025. The late-breaking presentation will focus on response rates for vilastobart in combination with atezolizumab in patients with microsatellite stable metastatic colorectal cancer  who have high plasma tumor mutational burden. The data will be available in a poster session on November 7, 2025, and will also be posted on the Xilio Therapeutics website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDLbG66lP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BKPKM429.USD","BK4588","LU2095319765.USD","IE00B64PRP62.GBP","LU2210149790.SGD","LU2210150020.SGD","IE00BGHQF748.EUR","NDAQ","BK4112","XLO","BK4139","IE00B3QW5Z07.USD","LU0314104364.USD"],"gpt_icon":0},{"id":"2574102232","title":"Xilio Therapeutics Inc announces date for special stockholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2574102232","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574102232?lang=en_us&edition=fundamental","pubTime":"2025-10-11 04:04","pubTimestamp":1760126688,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nNDL4qxyRl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2572654500","title":"Xilio Therapeutics Announces New Clinical Data for Tumor-Activated Immunotherapies at SITC 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2572654500","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572654500?lang=en_us&edition=fundamental","pubTime":"2025-10-03 21:00","pubTimestamp":1759496424,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc., a clinical-stage biotechnology company focused on tumor-activated immuno-oncology therapies, has announced multiple upcoming presentations at the Society for Immunotherapy of Cancer  40th Annual Meeting, scheduled for November 6-9, 2025, at the Gaylord National Convention Center in National Harbor, Maryland. The company will present new clinical data on vilastobart, a tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4, and efarindodekin alfa , a tumor-activated IL-12. Additionally, preclinical data on Xilio's masked T cell engager programs will be showcased. Specific poster presentations include an analysis of ctDNA as a potential surrogate biomarker for response to combination vilastobart and atezolizumab in heavily pretreated microsatellite stable metastatic colorectal cancer, pharmacodynamic data from the first-in-human phase 1 study of XTX301 in advanced solid tumors, and data on masked T cell engagers designed for synthetic anti-tumor immunity","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL381D2t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU2210149790.SGD","BK4112","IE00B3QW5Z07.USD","LU2095319765.USD","BK4139","LU0314104364.USD","NDAQ","IE00BGHQF748.EUR","IE00BKPKM429.USD","XLO","IE00B64PRP62.GBP","BK4585","BK4588"],"gpt_icon":0},{"id":"2572500636","title":"Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer (SITC) 40TH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2572500636","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572500636?lang=en_us&edition=fundamental","pubTime":"2025-10-03 21:00","pubTimestamp":1759496400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nTUA5GWDP3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2572502929","title":"BRIEF-Xilio Therapeutics Transfers Listing Of Co's Common Stock To Nasdaq Capital Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2572502929","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572502929?lang=en_us&edition=fundamental","pubTime":"2025-10-03 20:03","pubTimestamp":1759493034,"startTime":"0","endTime":"0","summary":"BRIEF-Xilio Therapeutics Transfers Listing Of Co's Common Stock To Nasdaq Capital MarketOct 3  - SEC Filing:XILIO THERAPEUTICS - TRANSFERS LISTING OF CO'S COMMON STOCK TO NASDAQ CAPITAL MARKET,EFFECTIVE OCTOBER 6 - SEC FILINGSource text: [ID:n0001193125-25-229231]Further company coverage: XLO.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nFWN3VJ0JA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2572504181","title":"Xilio Therapeutics - Transfers Listing of Co's Common Stock to Nasdaq Capital Market,Effective October 6 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2572504181","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572504181?lang=en_us&edition=fundamental","pubTime":"2025-10-03 19:34","pubTimestamp":1759491254,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nFWN3VJ0JA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2572504919","title":"Xilio Therapeutics Transfers to Nasdaq Capital Market After Failing to Meet Minimum Bid Price Requirement; Granted Additional 180 Days to Regain Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2572504919","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572504919?lang=en_us&edition=fundamental","pubTime":"2025-10-03 19:30","pubTimestamp":1759491048,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Transfers to Nasdaq Capital Market After Failing to Meet Minimum Bid Price Requirement; Granted Additional 180 Days to Regain Compliance. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 03, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL48Sb1l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2566765691","title":"BRIEF-Xilio Starts Phase 2 Trial for XTX301, Hits $17.5M Milestone in Gilead License Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2566765691","media":"Reuters","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566765691?lang=en_us&edition=fundamental","pubTime":"2025-09-09 19:37","pubTimestamp":1757417834,"startTime":"0","endTime":"0","summary":"BRIEF-Xilio Starts Phase 2 Trial for XTX301, Hits $17.5M Milestone in Gilead License DealSept 9 (Reuters) - Xilio Therapeutics Inc XLO.O:XILIO THERAPEUTICS ANNOUNCES INITIATION OF PHASE 2 TRIAL FOR EF","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nTUA6RSKMV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2566279691","title":"Xilio Therapeutics Extends Cash Runway into Q1 2027 Following $17.5 Million Milestone Achievement","url":"https://stock-news.laohu8.com/highlight/detail?id=2566279691","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566279691?lang=en_us&edition=fundamental","pubTime":"2025-09-09 19:30","pubTimestamp":1757417427,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics, Inc., a clinical-stage biotechnology company, has provided financial guidance indicating a solid cash position. As of June 30, 2025, the company reported cash and cash equivalents totaling $121.6 million. With the recent achievement of a $17.5 million development milestone under its license agreement with Gilead Sciences, Inc., Xilio anticipates that this financial reserve will support its operating expenses and capital expenditure needs into the first quarter of 2027. The company expects to receive the payment for the milestone by the fourth quarter of 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on Se","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nNDLb5cVx2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU1778281490.HKD","BK4550","SG9999015952.SGD","LU0314104364.USD","IE00B7SZLL34.SGD","LU2324357040.USD","IE00B19Z3581.USD","LU0889565916.HKD","BK4568","LU2210149790.SGD","BK4583","SG9999015986.USD","BK4112","IE00B64PRP62.GBP","LU1674673428.USD","BK4532","BK4578","LU1839511570.USD","LU2468319806.SGD","IE00B3QW5Z07.USD","IE00B19Z3B42.SGD","LU1430594728.SGD","LU2089984988.USD","SG9999015945.SGD","IE00BKPKM429.USD","GILD","LU0320765992.SGD","LU1066053197.SGD","LU0823416689.USD","LU1674673691.USD","BK4585","IE00BGHQF748.EUR","IE00BSNM7G36.USD","LU1066051498.USD","LU0114720955.EUR","LU2087621335.USD","IE0002270589.USD","LU1571399168.USD","BK4139","LU0882574055.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","SG9999015978.USD","LU0109394709.USD","XLO","BK4588","LU1585245621.USD","NDAQ","LU0058720904.USD"],"gpt_icon":0},{"id":"2563066575","title":"Xilio Therapeutics Inc. Faces Nasdaq Delisting Risk Due to Stockholders' Equity and Minimum Bid Price Non-Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2563066575","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563066575?lang=en_us&edition=fundamental","pubTime":"2025-08-29 04:06","pubTimestamp":1756411573,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc. has announced that it received a deficiency letter from the Nasdaq Stock Market on August 22, 2025, indicating non-compliance with the Nasdaq Global Select Market's requirement to maintain a minimum of $10 million in stockholders' equity. The company's equity was reported at $7,069,000 as of June 30, 2025. This follows an earlier notice in April 2025 regarding failure to maintain a $1.00 minimum bid price for its shares. Xilio has until October 6, 2025, to submit a compliance plan, with potential for a 180-day extension if the plan is accepted. The company is exploring options to address these issues, which currently have no immediate effect on its stock listing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDL2H58w9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2559952623","title":"Xilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2559952623","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559952623?lang=en_us&edition=fundamental","pubTime":"2025-08-14 20:22","pubTimestamp":1755174167,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryXilio Therapeutics Inc XLO.OQ reported a quarterly adjusted loss of 16 cents per share for the quarter ended June","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nL8N3U60VT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO"],"gpt_icon":0},{"id":"2559269951","title":"BRIEF-Xilio Therapeutics Q2 Net Income USD -15.844 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2559269951","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559269951?lang=en_us&edition=fundamental","pubTime":"2025-08-14 19:30","pubTimestamp":1755171046,"startTime":"0","endTime":"0","summary":"BRIEF-Xilio Therapeutics Q2 Net Income USD -15.844 Million\n\n\nAug 14 (Reuters) - Xilio Therapeutics Q2 operating expenses USD 22.45 million.\n\nQ2 basic EPS USD -0.16\nQ2 income from operations USD -14.366 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nPLXA29882:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2559514219","title":"Xilio Therapeutics Reports Q2 2025 Results: Collaboration and License Revenue Surges to $8.1M; Net Loss Widens to $15.8M","url":"https://stock-news.laohu8.com/highlight/detail?id=2559514219","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559514219?lang=en_us&edition=fundamental","pubTime":"2025-08-14 19:30","pubTimestamp":1755171043,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on August 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL2BPFG7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","NDAQ","ABBV","GILD"],"gpt_icon":0},{"id":"2559951754","title":"Xilio Therapeutics Inc: on Track to Nominate First Development Candidates for Wholly Owned Masked T Cell Engager Programs in H2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2559951754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559951754?lang=en_us&edition=fundamental","pubTime":"2025-08-14 19:30","pubTimestamp":1755171001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nPLXA29882:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2557301717","title":"Xilio Therapeutics Initiated at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2557301717","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557301717?lang=en_us&edition=fundamental","pubTime":"2025-08-07 03:06","pubTimestamp":1754507160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/XLO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 06, 2025 15:06 ET (19:06 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","XLO"],"gpt_icon":0},{"id":"2557379685","title":"Leerink Partners Initiates Xilio Therapeutics at Outperform With $2 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2557379685","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557379685?lang=en_us&edition=fundamental","pubTime":"2025-08-06 19:38","pubTimestamp":1754480288,"startTime":"0","endTime":"0","summary":"Leerink Partners Initiates Xilio Therapeutics at Outperform With $2 Price Target","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLO","LENZ"],"gpt_icon":0},{"id":"2556538928","title":"Catalyst Pharmaceuticals Appoints Daniel Curran, Md, to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2556538928","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556538928?lang=en_us&edition=fundamental","pubTime":"2025-08-04 20:03","pubTimestamp":1754308980,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nTUA1ZCDWZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0034390439.USD","XLO","CPRX","BK4139","IE00B19Z6F94.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":39,"code":"91000000","status":"200"}]}}